Colorectal cancer (CRC) refers to cancer that develops in the colon (large intestine) or rectum (the lower part of the large intestine). As we wrap March and CRC Awareness month, here are key points according to the experts, foundations, and alliances:
- It is one of the most common types of cancer worldwide.
- It typically starts as non-cancerous polyps that can gradually turn into cancer.
- Risk factors include age, family history, smoking, obesity, and a low-fiber diet.
- Symptoms may include changes in bowel habits, blood in the stool, abdominal pain, and weight loss.
- Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapy.
Early detection through screening is crucial for improving survival rates.
Celebrity Colon Cancer Deaths Spotlight Importance of Early Screenings
We have sadly seen many beloved celebrities, athletes, and actors pass away due to complications from colon cancer. A sobering reminder for all patients of the importance of getting regular colon cancer screenings. While any screening is better than none, the most effective way to screen for and prevent colon cancer continues to be colonoscopy. The US is now seeing a rising number of colon cancer diagnoses in younger adults: new cases of colorectal cancer increased more than 2% each year among people under 50 from 2012 to 2016, according to the American Cancer Society.
45 is the New 50
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the first patient has been enrolled in eAArly DETECT 2, a feasibility study to evaluate the Company’s next-generation colorectal cancer (CRC) test. The test integrates its proprietary mRNA biomarkers, an AI-developed algorithm, and a FIT test over a population of approximately 2,000 average-risk patients to validate the industry-leading results of previous feasibility studies and support the transition of CRC screening to CRC prevention.
